ARTICLE | Company News
CVTX and Fujisawa in cardiac imaging deal
July 11, 2000 7:00 AM UTC
Fujisawa Healthcare (Deerfield, Ill.) received exclusive North American rights to CV Therapeutics' CVT-3146 short acting selective A2A adenosine receptor agonist, and another backup compound for cardi...